Literature DB >> 25634982

Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.

Hidetaka Noma1, Tatsuya Mimura2, Kanako Yasuda1, Masahiko Shimura1.   

Abstract

PURPOSE: The association between aqueous humor levels of various growth/inflammatory factors or cytokines and the severity of macular edema was investigated in patients with central retinal vein occlusion (CRVO).
METHODS: Aqueous humor levels of 11 factors or cytokines were measured in CRVO patients with macular edema (n = 38) and in cataract patients (n = 15) as controls. Aqueous humor samples were obtained from the patients during surgery and the levels of VEGF, its receptors, and other factors or cytokines were measured by the suspension array method. The severity of macular edema was determined by measuring the central macular thickness, neurosensory retinal thickness, and subfoveal serous retinal thickness with optical coherence tomography.
RESULTS: Aqueous humor levels of growth factors, soluble VEGF receptor 1 (sVEGFR-1), sVEGFR-2, and inflammatory factors or cytokines were significantly higher in the CRVO group than in the control group. The aqueous level of sVEGFR-1 was significantly correlated with the neurosensory retinal thickness, as well as with the levels of growth factors (VEGF, placental growth factor, and platelet-derived growth factor-AA) and inflammatory factors/cytokines (monocyte chemotactic protein-1, interleukin-6, and interleukin-8). Aqueous humor levels of the three growth factors also were significantly correlated with each other, as were levels of the two sVEGFRs.
CONCLUSIONS: These findings suggest that growth/inflammatory factors and cytokines have an important role in macular edema associated with CRVO. Better understanding of the mechanisms involved may lead to development of new treatments, such as anti-VEGFR-1 therapy. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  central retinal vein occlusion; growth factor; inflammatory factor; macular edema; soluble vascular endothelial growth factor receptor

Mesh:

Substances:

Year:  2015        PMID: 25634982     DOI: 10.1167/iovs.14-15789

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

1.  The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.

Authors:  Hongfang Yong; Hui Qi; Hongtao Yan; Qianqian Wu; Ling Zuo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-01       Impact factor: 3.117

2.  Impact of allergy and atopy on the risk of pseudophakic cystoid macular edema.

Authors:  Friederike Schaub; Werner Adler; Meike C Koenig; Philip Enders; Rafael S Grajewski; Claus Cursiefen; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-24       Impact factor: 3.117

3.  Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion.

Authors:  Hai-Feng Qin; Fan-Jun Shi; Chao-Yang Zhang; Da-Wei Luo; Shi-Yue Qin; Jing Wu; Hai Xie; Jing-Ting Zhang; Qing-Hua Qiu; Kun Liu; Guo-Tong Xu; Guo-Xu Xu; Jing-Fa Zhang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

4.  EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Authors:  Laura Kowalczuk; Alexandre Matet; Ali Dirani; Alejandra Daruich; Aude Ambresin; Irmela Mantel; Richard F Spaide; Natacha Turck; Francine Behar-Cohen
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

5.  Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration.

Authors:  Ryosuke Motohashi; Hidetaka Noma; Kanako Yasuda; Osamu Kotake; Hiroshi Goto; Masahiko Shimura
Journal:  J Inflamm (Lond)       Date:  2018-12-04       Impact factor: 4.981

6.  Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion.

Authors:  Asako Mashima; Hidetaka Noma; Kanako Yasuda; Hiroshi Goto; Masahiko Shimura
Journal:  J Inflamm (Lond)       Date:  2019-05-22       Impact factor: 4.981

7.  Relationship between retinal blood flow and cytokines in central retinal vein occlusion.

Authors:  Hidetaka Noma; Kanako Yasuda; Tatsuya Mimura; Akemi Ofusa; Masahiko Shimura
Journal:  BMC Ophthalmol       Date:  2020-06-05       Impact factor: 2.209

Review 8.  Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.

Authors:  Teruyo Kida
Journal:  Biomed Res Int       Date:  2017-08-20       Impact factor: 3.411

9.  IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion.

Authors:  Lasse Jørgensen Cehofski; Anders Kruse; Svend Kirkeby; Alexander Nørgård Alsing; Jonas Ellegaard Nielsen; Kentaro Kojima; Bent Honoré; Henrik Vorum
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

10.  Prognostic indicators among laboratory data on arrival to assess the severity of mamushi bites.

Authors:  Ikuto Takeuchi; Kazuhiko Omori; Hiroki Nagasawa; Kei Jitsuiki; Akihiko Kondo; Hiromichi Ohsaka; Kouhei Ishikawa; Youichi Yanagawa
Journal:  J Rural Med       Date:  2019-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.